CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth

Neutral
AI Analysis

Summary

Emerald Clinical Trials announced the appointment of Michael Stibilj as Chief Executive Officer, effective October 1, 2026, to lead the organization's next phase of growth.

Importance:2/10
Sentiment:
0.00
ManagementLeadershipCRO
Related Companies

Read the original article

Published by PR Newswire Pharma on October 1, 2026 3:00 AM

Read Original